Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Conditions
Interventions
Intervention1: Nil: Nil
Control Intervention1: Nil: Nil
Sponsors
Kozhnosys Private Limited
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion Criteria for Test group (Breast Cancer group) 1. Willing to fill the informed consent form. 2. Female in the age group 20 to 80 years with/without common medical conditions like Hypertension, Hyperlipidaemia, Hypothyroidism, Arthritis, Asthma, GERD, Diabetes, PCOD, Vitamin D deficiency, Calcium Deficiency, Iron deficiency, Menopause, etc. (1) 3. Confirmed cases of breast cancer (Stage I-IV) as per positive mammogram report, positive tissue biopsy report and TNM staging done. 4.Confirmed cases of breast cancer but not exposed to any previous treatment cycle/surgery. Inclusion Criteria for Control group (1) Willing to fill the informed consent form. (2) Female in the age group 20 to 80 years. (3) Healthy subjects appearing for routine health check-up in hospital and having with negative mammogram and with/without common medical conditions like Hypertension, Hyperlipidemia, Hypothyroidism, Arthritis, Asthma, GERD, Diabetes, PCOD, Vitamin D deficiency, Calcium Deficiency, Iron deficiency, Menopause, Thyroid etc. (4) Willing to undertake routine mammography test.
Exclusion criteria
Exclusion criteria: Exclusion Criteria for Test group (Breast Cancer group), Other cancer group and Control group (1) Age group below 20 years. (2) Any known illness within 2 weeks from breath collection. (3) Already undergoing treatment for cancer. (4) Undergone surgery for breast tumour removal. (5) Positive, but no breast cancer on later investigation (Positive mammogram but negative biopsy report). (6) Drinking and smoking habits.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Training of CanScan sensor readings with respect to the biopsy reports (for breast cancer) and mammography reports (for the control group) for building machine learning model.Timepoint: 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| VOC (Volatile organic compounds) profile in cancer: Detection of biomarkers using Canscan prototype. 1.- Differentiation breath VOCs in cancer & healthy volunteers. 2.-Canscan prototype sensitivity & Specificity.Timepoint: 12 weeks | — |
Countries
India
Contacts
Public ContactJilma Peruvangat
Kozhnosys Private Limited
Outcome results
None listed